HOOKIPA to present Phase 1 safety, tolerability and preliminary anti-tumor activity data on HB-201 and HB-202 for the treatment of advanced HPV16+ cancers at ASCO

Press/Media

Period20 May 2021 → 21 May 2021

Media coverage

2

Media coverage

  • Title-HOOKIPA to present Phase 1 safety, tolerability and preliminary anti-tumor activity data on HB-201 and HB-202 for the treatment of advanced HPV16+ cancers at ASCO
    Media name/outletENP Newswire
    Country/TerritoryUnited Kingdom
    Date21/05/21
    PersonsDmitriy Zamarin
  • TitleHOOKIPA to present Phase 1 safety, tolerability and preliminary anti-tumor activity data on HB-201 and HB-202 for the treatment of advanced HPV16+ cancers at ASCO
    Media name/outletIndia Pharma News
    Country/TerritoryIndia
    Date20/05/21
    PersonsDmitriy Zamarin